Author:
Jenny Laura A.,Liu Pei-Kang,Kolesnikova Masha,Duong Jimmy,Kim Angela H.,Levi Sarah R.,Greenstein Vivienne C.,Tsang Stephen H.
Abstract
AbstractBietti crystalline dystrophy (BCD) is an ultra-rare orphan disorder that can lead to blindness. Because of the variable rates of progression of the disease, it is necessary to identify suitable outcome measurements for tracking progression in BCD. A retrospective analysis of patients with a clinical and genetic diagnosis of BCD was conducted. Four measurements of spectral domain-optical coherence tomography were compared to patients’ best corrected visual acuity. We observed that patients with higher measurements of foveolar thickness, choroidal thickness in the foveolar region, ellipsoid zone band length and the outer nuclear layer + area, had on average better visual acuity. Future studies are needed to validate the structural–functional correlations we observed in BCD and to propose a sensitive and clinically meaningful outcome measurement for tracking this rare, variable disease.
Funder
National Institutes of Health
Schneeweiss Stem Cell Fund, New York State
Foundation Fighting Blindness New York Regional Research Center Grant
Nancy & Kobi Karp
Crowley Family Funds
The Rosenbaum Family Foundation
Alcon Research Institute
Gebroe Family Foundation
Research to Prevent Blindness (RPB) Physician-Scientist Award
Publisher
Springer Science and Business Media LLC
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献